Francine Heatley is a Trial Manager at the UKCRC registered Imperial Clinical Trials Unit (ICTU) in the School of Public Health within the Faculty of Medicine at Imperial College.
Francine is a Biology graduate from the University of Nottingham and has over 10 years experience of conducting clinical research in therapeutic areas such as vascular surgery, cardiovascular and oncology . She spend 3 years working for an academic research organisation in Canada and is familiar in both Health Canada and FDA clinical trial regulations.
At ICTU she manages the EVRA (Early Venous Reflux Ablation) ulcer trial: A randomised clinical trial to compare early versus delayed endovenous treatment of superficial venous reflux in patients with chronic venous ulceration.
et al., 2019, Early versus deferred endovenous ablation of superficial venous reflux in patients with venous ulceration: the EVRA RCT, Health Technology Assessment, Vol:23, ISSN:1366-5278, Pages:1-+
et al., 2019, A multicenter randomized controlled study to evaluate whether neuromuscular electrical stimulation improves the absolute walking distance in patients with intermittent claudication compared with best available treatment, Journal of Vascular Surgery, Vol:69, ISSN:0741-5214, Pages:1567-1573
et al., 2019, Cost-effectiveness analysis of a randomized clinical trial of early versus deferred endovenous ablation of superficial venous reflux in patients with venous ulceration, British Journal of Surgery, Vol:106, ISSN:0007-1323, Pages:555-562
et al., 2018, Cost-effectiveness of treatments for superficial venous refluxin patients with chronic venous ulceration., Bjs Open, Vol:2, ISSN:2474-9842, Pages:203-212
et al., 2018, A randomized trial of early endovenous ablation in venous ulceration, New England Journal of Medicine, Vol:378, ISSN:0028-4793, Pages:2105-2114